发明名称 USE OF ISOXAZOLE AND CROTONAMIDE DERIVATIVE FOR MODULATION OF APOPTOSIS
摘要 PROBLEM TO BE SOLVED: To obtain a pharmaceutical agent capable of exhibiting modulation effect even on apoptosis by using a compound having an action to inhibit the dephosphorylation of cophylline as an active component. SOLUTION: This agent contains at least one kind of substance selected from a compound of the formula I and/or the formula II (R<1> is a 1-4C alkyl, a 3-5C cycloalkyl, etc.; R<2> is CF3 , O-CF3 , S-CF3 , OH, etc.; R<3> is a 1-4C alkyl, a halogen or H; X is CH or N atom) and/or its optical steric isomer and/or its physiologically permissible salt. The compound of the formula I or II is e.g. N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide. The administration rate of the compound of the formula I and/or the formula II is preferably 2-250mg, especially 10-50mg. The agent is expected to be useful for the treatment of infarction, fit, transplantation, autoimmune diseases, etc.
申请公布号 JPH1087484(A) 申请公布日期 1998.04.07
申请号 JP19970204344 申请日期 1997.07.30
申请人 HOECHST AG 发明人 MUELLNER STEFAN DR;DAX CLAUDIA DCH
分类号 C07D213/40;A61K31/275;A61K31/41;A61K31/42;A61K31/421;A61K31/435;A61K31/4418;A61K31/445;A61K38/13;A61K45/00;A61K45/06;A61P1/00;A61P9/08;A61P9/10;A61P11/00;A61P13/02;A61P15/00;A61P17/00;A61P29/00;A61P31/04;A61P31/12;A61P37/00;A61P43/00;C07D213/75;C07D263/34;C07D413/12;(IPC1-7):A61K31/275 主分类号 C07D213/40
代理机构 代理人
主权项
地址